Express Scripts Holding Company (NASDAQ:ESRX) investors are busy throwing a party this morning, following the news that health insurance giant CIGNA Corporation (NYSE:CI) intends to …
Gilead Sciences (NASDAQ: GILD) took a hit a few weeks ago when healthcare provider Express Scripts (NASDAQ: ESRX) chose AbbVie’s (NYSE: ABBV) hepatitis C drug over …
In a research report issued today, Oppenheimer analyst Bret Jones maintained an Outperform rating on Express Scripts (NASDAQ:ESRX) with a price target of …
Big Picture Thesis: Since Afrezza’s approval MannKind’s (NASDAQ:MNKD) shares have declined more than 50% as enthusiasm for their partnership with Sanofi-Aventis (NYSE:SNY) has …
